Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ1 chaperone protein
Autor: | García-Pupo, Laura, Crouzier, Lucie, Bencomo-Martínez, Alberto, Meunier, Johann, Morilleau, Axelle, Delprat, Benjamin, Carrazana, Marquiza Sablón, Menéndez Soto del Valle, Roberto, Maurice, Tangui, Rodríguez-Tanty, Chryslaine |
---|---|
Zdroj: | In Acta Pharmaceutica Sinica B October 2024 14(10):4345-4359 |
Databáze: | ScienceDirect |
Externí odkaz: |